For: | Yau MLY, Fung ELW, Ng PC. Response of levetiracetam in neonatal seizures. World J Clin Pediatr 2015; 4(3): 45-49 [PMID: 26261766 DOI: 10.5409/wjcp.v4.i3.45] |
---|---|
URL: | https://www.wjgnet.com/2219-2808/full/v4/i3/45.htm |
Number | Citing Articles |
1 |
Raffaele Falsaperla, Bruna Scalia, Andrea Giugno, Piero Pavone, Milena Motta, Martina Caccamo, Martino Ruggieri. Treating the symptom or treating the disease in neonatal seizures: a systematic review of the literature. Italian Journal of Pediatrics 2021; 47(1) doi: 10.1186/s13052-021-01027-2
|
2 |
Ronit M. Pressler, Nicholas S. Abend, Stéphan Auvin, Geraldine Boylan, Francesco Brigo, Maria Roberta Cilio, Linda S. De Vries, Maurizio Elia, Alberto Espeche, Cecil D. Hahn, Terrie Inder, Nathalie Jette, Angelina Kakooza‐Mwesige, Silke Mader, Eli M. Mizrahi, Solomon L. Moshé, Lakshmi Nagarajan, Iris Noyman, Magda L. Nunes, Pauline Samia, Eilon Shany, Renée A. Shellhaas, Ann Subota, Chahnez Charfi Triki, Tammy Tsuchida, Kollencheri Puthenveettil Vinayan, Jo M. Wilmshurst, Elissa G. Yozawitz, Hans Hartmann. Treatment of seizures in the neonate: Guidelines and consensus‐based recommendations—Special report from the ILAE Task Force on Neonatal Seizures. Epilepsia 2023; 64(10): 2550 doi: 10.1111/epi.17745
|
3 |
Seda Kanmaz, Özge Altun Köroğlu, Demet Terek, Hepsen Mine Serin, Erdem Simsek, İpek Dokurel Cetin, Sanem Yilmaz, Mehmet Yalaz, Gul Aktan, Mete Akisu, Nilgun Kultursay, Sarenur Gokben, Hasan Tekgul. Efficacy of levetiracetam as first-line therapy for neonatal clinical seizures and neurodevelopmental outcome at 12 months of age. Acta Neurologica Belgica 2021; 121(6): 1495 doi: 10.1007/s13760-020-01366-7
|
4 |
Veshni Pillay-Fuentes Lorente, Adrie Bekker, Gugu T J Kali, Lizel G Lloyd, Alma W Van der Merwe, Ahmed A Abulfathi, Eric H Decloedt. The Pharmacokinetics of Crushed Levetiracetam Tablets Administered to Neonates. Journal of Tropical Pediatrics 2021; 67(2) doi: 10.1093/tropej/fmab041
|
5 |
Lekha M. Rao, Charles J. Marcuccilli. Seizures in the Preterm Neonate. NeoReviews 2017; 18(1): e52 doi: 10.1542/neo.18-1-e52
|
6 |
Irina B. Bondareva, Marina A. Ivzhits, Sergey K. Zyryanov, Mikhail S. Chenkurov. Therapeutic drug monitoring of levetiracetam in newborns. Annals of Clinical and Experimental Neurology 2019; 13(4): 65 doi: 10.25692/ACEN.2019.4.9
|
7 |
Elif Özalkaya, Sevilay Topcuoglu, Hande Karatepe, Abdülhamit Tüten, Tulin Gokmen, Guner Karatekin. Efficacy of levetiracetam in premature infants: our experience and review of the literature. The Journal of Maternal-Fetal & Neonatal Medicine 2019; 32(24): 4093 doi: 10.1080/14767058.2018.1481946
|
8 |
Meng-Yuan Qiao, Hong-Tao Cui, Ling-Zhi Zhao, Jing-Kun Miao, Qi-Xiong Chen. Efficacy and Safety of Levetiracetam vs. Phenobarbital for Neonatal Seizures: A Systematic Review and Meta-Analysis. Frontiers in Neurology 2021; 12 doi: 10.3389/fneur.2021.747745
|
9 |
Yu-Xing Ge, Xiang-Zhu Tian, Ying-Ying Lin, Xue-Yuan Liu. Chronic treatment with levetiracetam reverses deficits in hippocampal LTP in vivo in experimental temporal lobe epilepsy rats. Neuroscience Letters 2016; 628: 194 doi: 10.1016/j.neulet.2016.06.043
|
10 |
Elissa Yozawitz, Arthur Stacey, Ronit M. Pressler. Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy. Pediatric Drugs 2017; 19(6): 553 doi: 10.1007/s40272-017-0250-4
|
11 |
Tristan T. Sands, Tiffani L. McDonough. Recent Advances in Neonatal Seizures. Current Neurology and Neuroscience Reports 2016; 16(10) doi: 10.1007/s11910-016-0694-x
|
12 |
V. Lima-Rogel, E. J. López-López, S. E. Medellín-Garibay, L. M. Gómez-Ruiz, C. Romero-Méndez, R. C. Milán-Segovia, S. Romano-Moreno. Population pharmacokinetics of levetiracetam in neonates with seizures. Journal of Clinical Pharmacy and Therapeutics 2018; 43(3): 422 doi: 10.1111/jcpt.12658
|
13 |
Nicholas S. Abend, Courtney J. Wusthoff, Frances E. Jensen, Terrie E. Inder, Joseph J. Volpe. Volpe's Neurology of the Newborn. 2025; : 381 doi: 10.1016/B978-0-443-10513-5.00015-2
|
14 |
Lekha M. Rao, Shaun A. Hussain, Timothy Zaki, Alexander Cho, Teresa Chanlaw, Meena Garg, Raman Sankar. A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic–ischemic encephalopathy. Epilepsy & Behavior 2018; 88: 212 doi: 10.1016/j.yebeh.2018.09.015
|
15 |
Raffaele Falsaperla, Laura Mauceri, Piero Pavone, Massimo Barbagallo, Giovanna Vitaliti, Martino Ruggieri, Francesco Pisani, Giovanni Corsello. Short-Term Neurodevelopmental Outcome in Term Neonates Treated with Phenobarbital versus Levetiracetam: A Single-Center Experience. Behavioural Neurology 2019; 2019: 1 doi: 10.1155/2019/3683548
|
16 |
Debopam Samanta. Recent Advances in the Diagnosis and Treatment of Neonatal Seizures. Neuropediatrics 2021; 52(02): 073 doi: 10.1055/s-0040-1721702
|
17 |
Alexander M. Kreimer, Robert A. Littrell, Julia B. Gibson, Noelle R. Leung. Effectiveness of Levetiracetam as a First-Line Anticonvulsant for Neonatal Seizures. The Journal of Pediatric Pharmacology and Therapeutics 2019; 24(4): 320 doi: 10.5863/1551-6776-24.4.320
|
18 |
Nicholas S. Abend, Frances E. Jensen, Terrie E. Inder, Joseph J. Volpe. Volpe's Neurology of the Newborn. 2018; : 275 doi: 10.1016/B978-0-323-42876-7.00012-0
|